Around the World's Markets: London
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LEADING SHARES closed near an eight-week high, buoyed by gains in heavyweight drug shares and reassured by a firm Dow Jones average.
The FTSE 100 rose 28.8 points, or 0.46 per cent, to close at 6,280.8. At its best, the index hit 6,298.8, its highest intraday level since 10 September. A 4.4 per cent rise in SmithKline Beecham boosted the FTSE nine points, while Glaxo Wellcome and AstraZeneca rose more than 1.7 per cent each.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments